{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:12:15Z","timestamp":1790655135761,"version":"4.1.0"},"reference-count":40,"publisher":"Pharmaceutical Society of Japan","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,4,24]]},"DOI":"10.1248\/bpb.b25-00009","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T22:07:24Z","timestamp":1745446044000},"page":"422-431","source":"Crossref","is-referenced-by-count":5,"title":["Esaxerenone Improves Vascular Endothelial Dysfunction by Reducing Serum and Glucocorticoid-Regulated Kinase 1 Activity and Enhancing the Akt Pathway in Type 2 Diabetic Mice"],"prefix":"10.1248","volume":"48","author":[{"given":"Kumiko","family":"Taguchi","sequence":"first","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University, 2\u20134\u201341 Ebara, Shinagawa-ku, Tokyo 142\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University, 2\u20134\u201341 Ebara, Shinagawa-ku, Tokyo 142\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Second Department of Pharmacology, School of Pharmaceutical Sciences, Kyushu University of Medical Science, 1714\u20131 Yoshino-cho, Nobeoka, Miyazaki 882\u20138508, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University, 2\u20134\u201341 Ebara, Shinagawa-ku, Tokyo 142\u20138501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Di Francescomarino S, Sciartilli A, Di Valerio V, Di Baldassarre A, Gallina S. The effect of physical exercise on endothelial function. <i>Sports Med.<\/i>, <b>39<\/b>, 797\u2013812 (2009).","DOI":"10.2165\/11317750-000000000-00000"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. <i>J. Am. Coll. Cardiol.<\/i>, <b>42<\/b>, 1149\u20131160 (2003).","DOI":"10.1016\/S0735-1097(03)00994-X"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. <i>Diabetes Care<\/i>, <b>34<\/b><b>(<\/b>Suppl. 2<b>)<\/b>, S285\u2013S290 (2011).","DOI":"10.2337\/dc11-s239"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Fetterman JL, Holbrook M, Westbrook DG, Brown JA, Feeley KP, Breton-Romero R, Linder EA, Berk BD, Weisbrod RM, Widlansky ME, Gokce N, Ballinger SW, Hamburg NM. Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease. <i>Cardiovasc. Diabetol.<\/i>, <b>15<\/b>, 53 (2016).","DOI":"10.1186\/s12933-016-0372-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Casanova F, Adingupu DD, Adams F, Gooding KM, Looker HC, Aizawa K, Dove F, Elyas S, Belch JJF, Gates PE, Littleford RC, Gilchrist M, Colhoun HM, Shore AC, Khan F, Strain WD. The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control. <i>Cardiovasc. Diabetol.<\/i>, <b>16<\/b>, 114 (2017).","DOI":"10.1186\/s12933-017-0594-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. <i>JAMA<\/i>, <b>291<\/b>, 1978\u20131986 (2004).","DOI":"10.1001\/jama.291.16.1978"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes. <i>J. Diabetes<\/i>, <b>9<\/b>, 434\u2013449 (2017).","DOI":"10.1111\/1753-0407.12521"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Siragusa M, Fleming I. The eNOS signalosome and its link to endothelial dysfunction. <i>Pflugers Arch.<\/i>, <b>468<\/b>, 1125\u20131137 (2016).","DOI":"10.1007\/s00424-016-1839-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn\u2019t calcium\/calmodulin enough. <i>J. Pharmacol. Exp. Ther.<\/i>, <b>299<\/b>, 818\u2013824 (2001).","DOI":"10.1016\/S0022-3565(24)29198-9"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. <i>Am. J. Physiol. Regul. Integr. Comp. Physiol.<\/i>, <b>284<\/b>, R1\u2013R12 (2003).","DOI":"10.1152\/ajpregu.00323.2002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Taguchi K, Kobayashi T, Takenouchi Y, Matsumoto T, Kamata K. Angiotensin II causes endothelial dysfunction <i>via<\/i> the GRK2\/Akt\/eNOS pathway in aortas from a murine type 2 diabetic model. <i>Pharmacol. Res.<\/i>, <b>64<\/b>, 535\u2013546 (2011).","DOI":"10.1016\/j.phrs.2011.05.001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Taguchi K, Matsumoto T, Kamata K, Kobayashi T. Inhibitor of G protein-coupled receptor kinase 2 normalizes vascular endothelial function in type 2 diabetic mice by improving <i>\u03b2<\/i>-arrestin 2 translocation and ameliorating Akt\/eNOS signal dysfunction. <i>Endocrinology<\/i>, <b>153<\/b>, 2985\u20132996 (2012).","DOI":"10.1210\/en.2012-1101"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Fern\u00e1ndez-Hernando C, Ackah E, Yu J, Su\u00e1rez Y, Murata T, Iwakiri Y, Prendergast J, Miao RQ, Birnbaum MJ, Sessa WC. Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease. <i>Cell Metab.<\/i>, <b>6<\/b>, 446\u2013457 (2007).","DOI":"10.1016\/j.cmet.2007.10.007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. <i>N. Engl. J. Med.<\/i>, <b>341<\/b>, 709\u2013717 (1999).","DOI":"10.1056\/NEJM199909023411001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Bruder-Nascimento T, da Silva MA, Tostes RC. The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes. <i>Diabetol. Metab. Syndr.<\/i>, <b>6<\/b>, 90 (2014).","DOI":"10.1186\/1758-5996-6-90"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nakamura T, Fukuda M, Kataoka K, Nako H, Tokutomi Y, Dong YF, Yamamoto E, Yasuda O, Ogawa H, Kim-Mitsuyama S. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats. <i>Hypertens. Res.<\/i>, <b>34<\/b>, 817\u2013824 (2011).","DOI":"10.1038\/hr.2011.35"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Munkhjargal U, Fukuda D, Ganbaatar B, Suto K, Matsuura T, Ise T, Kusunose K, Yamaguchi K, Yagi S, Yamada H, Soeki T, Wakatsuki T, Sata M. A Selective mineralocorticoid receptor blocker, esaxerenone, attenuates vascular dysfunction in diabetic C57BL\/6 Mice. <i>J. Atheroscler. Thromb.<\/i>, <b>30<\/b>, 326\u2013334 (2023).","DOI":"10.5551\/jat.63382"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Arai K, Tsuruoka H, Homma T. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats. <i>Eur. J. Pharmacol.<\/i>, <b>769<\/b>, 266\u2013273 (2015).","DOI":"10.1016\/j.ejphar.2015.11.028"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Gao X, Chang J, Chang Y, Fan L, Liu Z, Zhang C, Shimosawa T, Yang F, Xu Q. Esaxerenone inhibits renal angiogenesis and endothelial-mesenchymal transition <i>via<\/i> the VEGFA and TGF-<i>\u03b2<\/i>1 pathways in aldosterone-infused mice. <i>Int. J. Mol. Sci.<\/i>, <b>24<\/b>, 11766 (2023).","DOI":"10.3390\/ijms241411766"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kobayashi T, Taguchi K, Yasuhiro T, Matsumoto T, Kamata K. Impairment of PI3-K\/Akt pathway underlies attenuated endothelial function in aorta of type 2 diabetic mouse model. <i>Hypertension<\/i>, <b>44<\/b>, 956\u2013962 (2004).","DOI":"10.1161\/01.HYP.0000147559.10261.a7"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Taguchi K, Kaneko N, Okudaira K, Matsumoto T, Kobayashi T. Endothelial dysfunction caused by circulating microparticles from diabetic mice is reduced by PD98059 through ERK and ICAM-1. <i>Eur. J. Pharmacol.<\/i>, <b>913<\/b>, 174630 (2021).","DOI":"10.1016\/j.ejphar.2021.174630"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Taguchi K, Hida M, Matsumoto T, Kobayashi T. Resveratrol ameliorates clonidine-induced endothelium-dependent relaxation involving Akt and endothelial nitric oxide synthase regulation in Type 2 diabetic mice. <i>Biol. Pharm. Bull.<\/i>, <b>38<\/b>, 1864\u20131872 (2015).","DOI":"10.1248\/bpb.b15-00403"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Voelkl J, Luong TT, Tuffaha R, Musculus K, Auer T, Lian X, Daniel C, Zickler D, Boehme B, Sacherer M, Metzler B, Kuhl D, Gollasch M, Amann K, M\u00fcller DN, Pieske B, Lang F, Alesutan I. SGK1 induces vascular smooth muscle cell calcification through NF-\u03baB signaling. <i>J. Clin. Invest.<\/i>, <b>128<\/b>, 3024\u20133040 (2018).","DOI":"10.1172\/JCI96477"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Borst O, Schaub M, Walker B, Schmid E, M\u00fcnzer P, Voelkl J, Alesutan I, Rodr\u00edguez JM, Vogel S, Schoenberger T, Metzger K, Rath D, Umbach A, Kuhl D, M\u00fcller II, Seizer P, Geisler T, Gawaz M, Lang F. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis. <i>Arterioscler. Thromb. Vasc. Biol.<\/i>, <b>35<\/b>, 547\u2013557 (2015).","DOI":"10.1161\/ATVBAHA.114.304454"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Knapp M, Tu X, Wu R. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. <i>Acta Pharmacol. Sin.<\/i>, <b>40<\/b>, 1\u20138 (2019).","DOI":"10.1038\/s41401-018-0042-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Sch\u00e4fer N, Lohmann C, Winnik S, van Tits LJ, Miranda MX, Vergopoulos A, Ruschitzka F, Nussberger J, Berger S, L\u00fcscher TF, Verrey F, Matter CM. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity. <i>Eur. Heart J.<\/i>, <b>34<\/b>, 3515\u20133524 (2013).","DOI":"10.1093\/eurheartj\/eht095"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Silva MA, Bruder-Nascimento T, Cau SB, Lopes RA, Mestriner FL, Fais RS, Touyz RM, Tostes RC. Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO\/GC signaling. <i>Front. Physiol.<\/i>, <b>6<\/b>, 269 (2015).","DOI":"10.3389\/fphys.2015.00269"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Arai K, Homma T, Morikawa Y, Ubukata N, Tsuruoka H, Aoki K, Ishikawa H, Mizuno M, Sada T. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist. <i>Eur. J. Pharmacol.<\/i>, <b>761<\/b>, 226\u2013234 (2015).","DOI":"10.1016\/j.ejphar.2015.06.015"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Raz-Pasteur A, Gamliel-Lazarovich A, Coleman R, Keidar S. Eplerenone reduced lesion size in early but not advanced atherosclerosis in apolipoprotein E-deficient mice. <i>J. Cardiovasc. Pharmacol.<\/i>, <b>60<\/b>, 508\u2013512 (2012).","DOI":"10.1097\/FJC.0b013e31826f5535"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Raghavan S, Vassy JL, Ho YL, Song RJ, Gagnon DR, Cho K, Wilson PWF, Phillips LS. Diabetes mellitus- related all-cause and cardiovascular mortality in a national cohort of adults. <i>J. Am. Heart Assoc.<\/i>, <b>8<\/b>, e011295 (2019).","DOI":"10.1161\/JAHA.118.011295"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. <i>Circ. Res.<\/i>, <b>90<\/b>, 1243\u20131250 (2002).","DOI":"10.1161\/01.RES.0000022200.71892.9F"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher A. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. <i>Nature<\/i>, <b>399<\/b>, 601\u2013605 (1999).","DOI":"10.1038\/21224"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Huang X, Liu G, Guo J, Su Z. The PI3K\/AKT pathway in obesity and type 2 diabetes. <i>Int. J. Biol. Sci.<\/i>, <b>14<\/b>, 1483\u20131496 (2018).","DOI":"10.7150\/ijbs.27173"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Janus A, Szahidewicz-Krupska E, Mazur G, Doroszko A. Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders. <i>Mediators Inflamm.<\/i>, <b>2016<\/b>, 3634948 (2016).","DOI":"10.1155\/2016\/3634948"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Penela P, Ribas C, Mayor F Jr. Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. <i>Cell. Signal.<\/i>, <b>15<\/b>, 973\u2013981 (2003).","DOI":"10.1016\/S0898-6568(03)00099-8"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Liu S, Premont RT, Kontos CD, Zhu S, Rockey DC. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. <i>Nat. Med.<\/i>, <b>11<\/b>, 952\u2013958 (2005).","DOI":"10.1038\/nm1289"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Mutoh A, Isshiki M, Fujita T. Aldosterone enhances ligand-stimulated nitric oxide production in endothelial cells. <i>Hypertens. Res.<\/i>, <b>31<\/b>, 1811\u20131820 (2008).","DOI":"10.1291\/hypres.31.1811"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Salker MS, Christian M, Steel JH, Nautiyal J, Lavery S, Trew G, Webster Z, Al-Sabbagh M, Puchchakayala G, Foller M, Landles C, Sharkey AM, Quenby S, Aplin JD, Regan L, Lang F, Brosens JJ. Deregulation of the serum- and glucocorticoid-inducible kinase sgk1 in the endometrium causes reproductive failure. <i>Nat. Med.<\/i>, <b>17<\/b>, 1509\u20131513 (2011).","DOI":"10.1038\/nm.2498"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Muter J, Brighton PJ, Lucas ES, Lacey L, Shmygol A, Quenby S, Blanks AM, Brosens JJ. Progesterone-dependent induction of phospholipase c-related catalytically inactive protein 1 (prip-1) in decidualizing human endometrial stromal cells. <i>Endocrinology<\/i>, <b>157<\/b>, 2883\u20132893 (2016).","DOI":"10.1210\/en.2015-1914"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Lang F, Shumilina E. Regulation of ion channels by the serum and glucocorticoid-inducible kinase SGK1. <i>FASEB J.<\/i>, <b>27<\/b>, 3\u201312 (2013).","DOI":"10.1096\/fj.12-218230"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/4\/48_b25-00009\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T03:23:51Z","timestamp":1745637831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/4\/48_b25-00009\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00009","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"article-number":"b25-00009"}}